相关实验视频
Updated: Jul 22, 2025

10:09
Optimization of a Quantitative Micro-neutralization Assay
Published on: December 14, 2016
21.3K
用于治疗儿童流感的RDN:一种随机,双盲,并行控制的临床试验
Shuo Yang1,2, Yan-Ming Xie3,4, Lian-Xin Wang5,6
1Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
BMC complementary medicine and therapies
|July 20, 2023
概括
调整注射 (RDN) 显示为儿童流感的安全和有效治疗的有希望的方法,为奥塞塔米维尔提供了替代方案. 这项研究评估了RDN RDN.
科学领域:
- 儿童传染病 儿童传染病
- 药理学 药理学是指药理学的学科.
- 传统中国医药 传统中国医药
背景情况:
- 儿童流感发病率有所上升.
- 红调注射 (RDN) 是一种具有抗炎,抗病毒和抗炎功能的中国草药配方.
- 对儿科流感的RDN评估至关重要.
研究的目的:
- 为了评估RDN的疗效和安全性,与小儿流感的奥塞尔塔米维尔相比.
- 探索RDN的抗病毒机制.
- 为合理的临床使用RDN提供证据.
主要方法:
- 随机,双盲,双模拟,多中心临床试验.
- 240名患有流感的儿科患者被随机分为1:1接受RDN或奥塞尔塔米维尔.
- 主要结局:温度恢复时间;次要结局:发烧降低,症状缓解,症状消失.
主要成果:
- 温度恢复时间是主要的结果指标.
- 二次结局包括发烧降低和症状缓解.
- 在注册前收集的数据和治疗后每24小时收集的数据.
结论:
- 这项研究旨在评估RDN在患有流感的儿童中的疗效和安全性.
- RDN可能为儿科流感提供另一种治疗选择.
- 基于证据的数据将支持临床药物使用.
相关概念视频
Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K

